Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile
Leigh Coney, Larissa J. Maier, Jason Ferris, Adam Winstock, Monica J. Barratt
Human Psychopharmacology Clinical and Experimental May 1, 2017 DOI: 10.1002/hup.2599 via OpenAlex
Summary
AI-generated from the abstractMost people who use LSD analogues (AL-LAD, 1P-LSD, ETH-LAD) have also tried LSD, and in the UK and US a higher proportion reported using analogues in the past year than LSD alone. Users described the effects as psychedelic, obtained the drugs online, and took them orally. The time to peak effect (2 hours) and duration (8 hours) were similar to LSD, but ratings for pleasurable high, strength, comedown, urge to use more drugs, value for money, and risk of harm were all significantly lower for the analogues compared with LSD. The authors suggest future studies should confirm these findings with chemical testing and dose measurement.
Study at a glance
| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 96,894 |
| Population | People who use drugs (Global Drug Survey 2016 respondents) |
| Keywords | Computer science Food science |
| Citations | 18 |
| Key finding | LSD analogues were reported as similar to LSD in time to peak and duration but weaker in strength, pleasurable high, and comedown. |
Abstract
Abstract Objective This study aimed to describe self‐reported patterns of use and effects of lysergic acid diethylamide (LSD) analogues (AL‐LAD, 1P‐LSD, and ETH‐LAD) and the characteristics of those who use them. Methods An anonymous self‐selected online survey of people who use drugs (Global Drug Survey 2016; N = 96,894), which measured perceived drug effects of LSD and its analogues. Results Most LSD analogue users (91%) had also tried LSD. The proportion of U.K. and U.S. respondents reporting LSD analogue use in the last 12 months was higher than for LSD only. LSD analogue users described the effects as psychedelic (93%), over half (55%) obtained it online, and almost all (99%) reported an oral route of administration. The modal duration (8 hr) and time to peak (2 hr) of LSD analogues were not significantly different from LSD. Ratings for pleasurable high, strength of effect, comedown, urge to use more drugs, value for money, and risk of harm following use were significantly lower for LSD analogues compared with LSD. Conclusions LSD analogues were reported as similar in time to peak and duration as LSD but weaker in strength, pleasurable high, and comedown. Future studies should seek to replicate these findings with chemical confirmation and dose measurement.